Peptide-Based Infection Therapeutics Market
According to Intent Market Research, the Peptide-Based Infection Therapeutics Market is expected to grow from USD 2.6 billion in 2024-e at a CAGR of 7.9% to touch USD 4.1 billion by 2030. The Peptide-Based Infection Therapeutics Market is dominated by key players such as, Pfizer, Novartis, Johnson &... Read More